NRC HEALTH
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
| ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
|---|
Our Credit Agreement provides that, in order for us to pay dividends or repurchase our common stock, there must be no default or event of default existing or that would result from such payment and we must show that we would comply with the Credit Agreement’s fixed charge coverage ratio and consolidated cash flow leverage ratio after giving pro forma effect to such payment.
The table below summarizes repurchases of common stock during the three months ended June 30, 2026.
| Period | Total Number of Shares Purchased | Average Price Paid per Share (1) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(2) |
|---|---|---|---|---|
| Apr 1 – Apr 30, 2026 | - | - | - | $58,066,938 |
| May 1 – May 31, 2026 | 342,866 | 18.63 | 342,866 | 51,684,874 |
| Jun 1 – Jun 30, 2026 | 54,515 | 18.86 | 54,515 | 50,657,850 |
| Total | 397,381 | 397,381 | $50,657,850 |
| (1) | The average price paid per share excludes excise tax incurred on stock repurchases. For the quarter ended June 30, 2026, no excise tax expense was incurred. |
| (2) | In March 2026, our Board of Directors authorized the 2026 Program, which authorizes the repurchase up to $60.0 million of our outstanding common stock through March 31, 2028. During the three months ended June 30, 2026, we repurchased 397,381 shares of our common stock for an aggregate of $7.4 million. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.